FRI-493 - Safety and signal intensity of a novel liver-specific MRI contrast agent, Orviglance® (manganese chloride tetrahydrate), in adult subjects with mild, moderate, or severe hepatic impairment

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 78; p. S841
Main Authors Hettiarachchige, Nadilka, Norlin, Andreas, Hedman, Hanna Persson, Lawitz, Eric
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.06.2023
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(23)02319-X